20th Century Year By Year 1977 schally, andrew V., USA, Veterans Administration Hospital, New Orleans, LA, b.1926 ( in Wilno, Poland) for their discoveries concerning the peptide http://www.historycentral.com/20th/1977.html
Portal Toolkit Invalid Site URL Miyazaki, Masahiro MD; schally, andrew V. PhD, MD; Nagy, Attila PhD; Lamharzi,Najib PhD; Halmos, Gabor PhD; Szepeshazi, Karoly MD; Armatis, Patricia MS http://ppv.ovid.com/pt/re/ajog/toc.00000447-199905000-00000.htm
Portal Toolkit Invalid Site URL Kleinman, Dita; Douvdevani, Amos; schally, andrew V.; Levy, Joseph; Sharoni, Yoav.Abstract HTML. 102. Tocolysis With Indomethacin Increases the Incidence http://ppv.ovid.com/pt/re/ajog/toc.00000447-199401000-00000.htm
United Sciences Of America Ph.D., Professor of Chemistry and Biochemistry, Louisiana State University;andrew V. schally, Ph.D., Chief, Department of Experimental Medicine, http://www.mlmwatch.org/04C/USA/usa.html
Extractions: United Sciences of America Stephen Barrett, M.D. United Sciences of America (USA) was a multilevel company based in Dallas, Texas. When it began marketing, its founder predicted gross sales of $150 million for 1986 and $1 billion by 1989 which would have made it the fastest growing company in U.S. history. Anyone could become a distributor by completing an application and paying $24.50 for a Success System Kit and Manual. By August 1986, USA claimed to have over 100,000 distributors and gross sales in line with its predictions. The company also set up a research foundation to generate research through grants and office-based studies. Its story is interesting because USA was the first MLM company to use high-tech videotapes and a prominent scientific advisory board as sales tools and was also the hardest hit by government regulators. USA was founded by Robert M. Adler II, a Dallas businessman who had become wealthy by developing a computer that dials phone numbers and engages in interactive messages. USA's corporate brochure listed nine co-founders, including: Jerris Leonard, a former U.S. Assistant Attorney General, was USA's president.
RESEARCHERS IDENTIFY NEW KIDNEY CANCER TREATMENT The targeted chemotherapy inhibited the tumors beautifully, said andrew V.schally, Ph.D., MDHC, distinguished medical research scientist at the New http://www1.va.gov/resdev/news/press_releases/kidney-cancer-053100.cfm
Extractions: Press Releases For immediate release May 31, 2000 Researchers from the Department of Veterans Affairs and colleagues have identified a promising new treatment for kidney cancer. Using a laboratory-developed analog of somatostatin, a hypothalamic hormone which inhibits the release of growth hormone, scientists were able to target specific receptors on tumor sites and reverse cancer growth. They report their findings in the June 1 issue of Cancer Research. "This analog is super potent. The targeted chemotherapy inhibited the tumors beautifully," said Andrew V. Schally, Ph.D., M.D.H.C., distinguished medical research scientist at the New Orleans VA Medical Center and leader of the research group. Dr. Schally, also a professor of medicine at Tulane University, received the Nobel Prize in Medicine in 1977. The analog used in the study, AN-238, has previously been shown effective in the treatment of prostate and breast cancers and brain tumors. This is the first application of the cytotoxic (cell-destroying) compound in renal cell carcinoma (RCC), the most common form of kidney cancer. RCC is diagnosed in an estimated 28,000 Americans each year and nearly 12,000 people died from the disease in 1999. These latest findings represent a great stride toward treatment of a cancer that has been resistant to both chemotherapy and radiation and has a very low survival rate.
VA R&D Research Honors andrew V. schally, PhD, DSc, MDhc, A clinical professor at Tulane University,Dr. schally conducts neuroscience and cancer research. http://www1.va.gov/resdev/about/organization/research_honors/june04.cfm
Extractions: ORD Research Honors June 2004 Andrew V. Schally, PhD, DSc, MDhc, senior medical investigator at the New Orleans VAMC, received the French Legion of Honor medal, one of France's highest honors, and the Regal National Academy of Medicine medal from Spain. Both honors recognize Schally's groundbreaking research into the interactions of hormones and cancers. In 1977, Schally received the Nobel Prize for Physiology and Medicine for his pioneering research on peptide hormones. A clinical professor at Tulane University, Dr. Schally conducts neuroscience and cancer research. Katherine N. Bent, PhD, RN, associate chief of nursing service at the VA Eastern Colorado Health Care System, was awarded the grand prize for a research poster by the Western Institute of Nursing. The prize acknowledges excellence in conduct and dissemination of a research project. Dr. Bent studies transitions in health care, including setting of care, types of care, and patient-centered care delivery models. She is an assistant professor at the University of Colorado Health Sciences Center's School of Nursing. Thomas P. Beresford, MD
AllRefer.com - Andrew Fielding Huxley Information And Facts W. Anderson Sir Nevill F. Mott John H. Van Vleck Rosalyn S. Yalow Roger C. L.Guillemin andrew V. schally Vicente Aleixandre 1978 Menachem Begin Anwar http://search.allrefer.com/cgi-bin/allrefer-reference.cgi?q=Andrew Fielding Huxl
TUHSC 170th Anniversary Website andrew V. schally received the 1977 Nobel Prize in Medicine or Physiology forhis discovery of the thyrotropinreleasing hormone (TRH) and luteinizing http://alumni.hsc.tulane.edu/170th/schally_details.html
TUHSC 170th Anniversary Website andrew V. schally, who received the 1977 Nobel Prize in Medicine or Physiologyfor his discovery of the thyrotropinreleasing hormone (TRH) and luteinizing http://alumni.hsc.tulane.edu/170th/pr_nobel_prizes.htm
Extractions: American medical physicist. She shared a 1977 Nobel Prize for research on hormones. Encyclopedia Yalow, Rosalyn Sussman, 1921â, American medical physicist, b. New York City, Ph.D. Univ. of Illinois, 1945. As a researcher at the Bronx Veterans Administration Hospital, Yalow and colleague Solomon A. Berson developed a process, called radioimmunoassay (RIA), that made it possible to detect mere traces of biological substances in blood and other fluids. For her work, Yalow was awarded the 1977 Nobel Prize in Physiology or Medicine along with Andrew V. Schally and Roger Guillemin Wikipedia Rosalyn Sussman Yalow Rosalyn Sussman Yalow (born on July 19 ) is an American medical physicist , and a co-winner of the Nobel Prize in Physiology or Medicine for her development of the radioimmunoassay (RIA) technique.
LP Nobel Prizes (Men Vs Women) Hamilton O. Smith, 1977 Roger Guillemin, andrew V. schally, 1976 Baruch S.Blumberg, D. Carleton Gajdusek, 1975 David Baltimore, Renato Dulbecco, http://www.libertypost.org/cgi-bin/readart.cgi?ArtNum=103984
Previous Gairdner Foundation Winners Roger Guillemin, andrew V. schally, Hans J. MüllerEberhard. Judah H. Quastel.1973, Roscoe O. Brady, Denis P. Burkitt, John Charnley http://www.gairdner.org/priorwinner.html
Extractions: The Foundation is proud to present a complete list of winners from previous years and congratulate all of them on their impressive list of achievements and their contributions to our understanding of health, healing and the natural world. To return to the Foundation home page, click here Jeffrey M. Friedman Douglas Coleman Craig C. Mello ... James D. Watson (Award of Merit) Clay Armstrong Bertil Hille Roderick MacKinnon Marc Kirschner ... Janet D. Rowley Bruce M. Alberts Arthur Kornberg Roger Y. Tsien Pamela J. Bjorkman Don C. Wiley Tony Hunter Anthony J. Pawson Donald Metcalf Mario R. Capecchi Oliver Smithies Alvin R. Feinstein Stanley B. Prusiner Michel M. Ter-Pogossian Leland H. Hartwell Yoshio Masui Paul M. Nurse Richard Peto Bert Vogelstein Robert A. Weinberg John R. Evans (Wightman) Sydney Brenner John E. Sulston M. Judah Folkman Robert F. Furchgott David H. MacLennan Kary B. Mullis Francis S. Collins John R. Riordan Lap-Chee Tsui Victor Ling Oliver Smithies Edwin M. Southern E. Donnall Thomas Mark M. Davis Tak W. Mak Jean-Marie Ghuysen Louis M. Kunkel
Senior Physiologists' News I returned to Tulane again in 1965, to work with Dr. andrew V. schally to isolateand identify the hypothalamic hormones as the chief physiologist. http://www.the-aps.org/publications/tphys/2004html/FebTphys/srphys.htm
Extractions: Im officially retired! Albeit, I still see cardiac consultations at the hospital four mornings a week and work on research projects related to the pulmonary circulation every afternoon with my younger colleague, Phil Kadawitz. Were still turning out good MD-PhDs and PhDs in pharmacologya work that keeps quite an courrant and excited. The email of NIH grant applications is always upon us. The cardiology section at Tulane where my primary appointment remains, erected a surprise wall poster for my birthday and it displayed much of the cardiac catheterization work Id done since 1947(!). When I saw it, quite by accident, as I collected my mail and the announcements, I was truly overwhelmed. Then just before the usual Friday noon pharmacology seminars, the Chairman, Krishna Agawald, and Phil, surprised me with a birthday party and dedicated the seminar to me.
Intellectual Output From The Arab World 1977 andrew V. schally 1978 - Daniel Nathans 1980 - Baruj Benacerraf 1984 -Cesar Milstein 1985 - Michael Stuart Brown 1985 - Joseph L. Goldstein http://www.masada2000.org/nobel.html
Extractions: The Norwegians played an ugly joke on the world by pretending Arafat was a Man of Peace. G-d corrected that mistake by giving Arafat by him Here Note: Elias James Corey ( Chemistry 1990) , Peter Brian Medawar (Medicine 1960) and Ferid Mourad (Medicine 1998) are Nobel Prize winners but are Arab- Christians , not Muslims.
Extractions: Section of Experimental Medicine, Tulane University School of Medicine and Endocrine, Polypeptide, and Cancer Institute, The Veterans Affairs Medical Center, New Orleans, Los Angeles USA (Correspondence should be addressed to A V Schally, Veterans Affairs Medical Center, 1601 Perdido Street, New Orleans, Los Angeles, USA) In view of non-specific toxicity of most chemotherapeutic agents against normal cells, the development of targeted chemotherapy is warranted. Efficient targeting of chemotherapeutic drugs to the cancerous area could be of great benefit for patients with advanced or metastatic tumors. Targeted cytotoxic peptide conjugates are hybrid molecules composed of a peptide carrier which binds to receptors on tumors and a cytotoxic moiety. New cytotoxic analogs of LH-RH, AN-152 in which doxorubicin (DOX) is linked to [D-Lys ]LH-RH, and AN-207 which consists of 2- pyrrolino-DOX (AN-201) coupled to the same carrier, show high-affinity binding and are much less toxic and more effective in vivo Download the FULL TEXT of this article in Acrobat PDF format.
Extractions: Abstract PDF (153 K) References (31) Permissions ... View full size inline images Anti-Cancer Drugs Volume 12(1) January 2001 pp 71-78 Arencibia, Jose M; Schally, Andrew V; Halmos, Gabor; Nagy, Attila; Kiaris, Hippokratis Endocrine, Polypeptide and Cancer Institute, Veterans Affairs Medical Center and Section of Experimental Medicine, Department of Medicine, Tulane University School of Medicine, New Orleans, LA 70112-1262, USA. Correspondence to AV Schally (151), VA Medical Center, 1601 Perdido Street, New Orleans, LA 70112-1262, USA. Tel: (+1) 504 589-5230; Fax: (+1) 504 566-1625 (Received 10 August 2000; accepted 10 October 2000) The work described in this paper was supported by the Medical Research Service of the Veterans Affairs Department and a grant from ASTA Medica, Frankfurt am Main, Germany to Tulane University School of Medicine (all to AVS) Article Outline Figures/Tables Targeting of cytotoxic agents represents a modern approach to the treatment of various cancers, that improves the efficacy and reduces peripheral toxicity. Recently we developed a powerful cytotoxic analog of luteinizing hormone-releasing hormone (LHRH), AN-207, designed to be targeted to tumors that express LHRH receptors. This analog consists of the superactive derivative of doxorubicin (DOX), 2-pyrrolino-DOX (AN-201), linked to [D-Lys
The Endocrinologist - UserLogin schally, andrew V.; Gual, Carlos. Endocrine, Polypeptide and Cancer Institute (AVS), Address correspondence to Dr. andrew V. schally (151), http://www.theendocrinologist.org/pt/re/endocrinologist/fulltext.00019616-200109
The Alfred B. Nobel Prize Winners: Physiology Or Medicine andrew V. schally, United States United States United States. 1978, Daniel NathansHamilton O. Smith Werner Arber, United States United States Switzerland http://history1900s.about.com/library/misc/blnobelmed.htm
Extractions: zJs=10 zJs=11 zJs=12 zJs=13 zc(5,'jsc',zJs,9999999,'') About Homework Help 20th Century History Homework Help ... Help zau(256,140,140,'el','http://z.about.com/0/ip/417/C.htm','');w(xb+xb+' ');zau(256,140,140,'von','http://z.about.com/0/ip/496/7.htm','');w(xb+xb); Sign Up Now for the 20th Century History newsletter!
Nobel-medicina 1977 Roger Guillemin, andrew V. schally, Rosalyn Yalow 1976 Baruch S. Blumberg, D.Carleton Gajdusek 1975 David Baltimore, Renato Dulbecco, Howard M. Temin http://buscabiografias.com/nobelmedicina.htm
